Back to search
FDAFDA · Food and drugs·Recall number D-0015-2021

Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40

Published October 14, 2020 · Recall initiated: September 9, 2020

Summary

FDA records drug Class III recall D-0015-2021, published October 14, 2020 and initiated September 9, 2020. Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 13480 cups; Lot: Lots: C1EE Exp. 04/2021, BD82 Exp. 11/2020, BD83 Exp. 11/2020, C16D Exp. 02/2021, C563 Exp. 11/2021, C574 Exp. 11/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Distributor
Nationwide.
Lot
Lots: C1EE Exp. 04/2021, BD82 Exp. 11/2020, BD83 Exp. 11/2020, C16D Exp. 02/2021, C563 Exp. 11/2021, C574 Exp. 11/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40 recalled?

Yes. FDA published recall D-0015-2021 on October 14, 2020. Reported hazard: Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint

What should I do if I have this product?

Voluntary: Firm initiated · Letter